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Abstract
Background: Approximately 5 to 10% of critically ill patients transition from acute critical illness to a state of
persistent and in some cases chronic critical illness. These patients have unique and complex needs that require a
change in the clinical management plan and overall goals of care to a focus on rehabilitation, symptom relief,
discharge planning, and in some cases, end-of-life care. However, existing indicators and measures of care quality,
and tools such as checklists, that foster implementation of best practices, may not be sufficiently inclusive in terms
of actionable processes of care relevant to these patients. Therefore, the aim of this systematic review is to identify
the processes of care, performance measures, quality indicators, and outcomes including reports of patient/family
experience described in the current evidence base relevant to patients with persistent or chronic critical illness and
their family members.
Methods: Two authors will independently search from inception to November 2016: MEDLINE, Embase, CINAHL,
Web of Science, the Cochrane Library, PROSPERO, the Joanna Briggs Institute and the International Clinical Trials
Registry Platform. We will include all study designs except case series/reports of <10 patients describing their study
population (aged 18 years and older) using terms such as persistent critical illness, chronic critical illness, and
prolonged mechanical ventilation. Two authors will independently perform data extraction and complete risk of
bias assessment. Our primary outcome is to determine actionable processes of care and interventions deemed
relevant to patients experiencing persistent or chronic critical illness and their family members. Secondary
outcomes include (1) performance measures and quality indicators considered relevant to our population of
interest and (2) themes related to patient and family experience.
Discussion: We will use our systematic review findings, with data from patient, family member and clinician
interviews, and a subsequent consensus building process to inform the development of quality metrics and tools to
measure processes of care, outcomes and experience for patients experiencing persistent or chronic critical illness
and their family members.
Systematic review registration: PROSPERO CRD42016052715
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Background
Advances in technology, establishment of evidence for
efficacy of interventions, and subsequent adoption into
practice have improved intensive care unit (ICU) survival
rates [1]. Notwithstanding these advancements, approxi-
mately 10% of critically ill patients transition from acute
critical illness to a state of persistent and in some cases
chronic critical illness [2]. Persistent critical illness is
reflected by ongoing critical illness and some degree of
instability that is no longer directly attributable to the ori-
ginal reason for ICU admission [3]. Patients with chronic
critical illness, in contrast, usually experience relative
clinical stability but continue to require prolonged ICU
stays and, in most cases, a prolonged need for mechanical
ventilation [4–6]. Patients with persistent or chronic
critical illness (P/CCI) experience a syndrome of ongoing
organ dysfunction, profound weakness, extreme symptom
burden, and ongoing physical and cognitive deficits result-
ing in a difficult and prolonged course of recovery [5, 7].
Family members also experience significant physical and
psychological burden, including anxiety, depression, and
post-traumatic stress disorder that arguably require an
enhanced level of support [8].
A recent population-based study of over one million
ICU patients in Australia and New Zealand identified
5% experienced persistent critical illness defined as a
length of stay of ≥10 days, but accounted for 33% of
ICU bed days and 15% of hospital bed days [9]. Similar
numbers in terms of persistent or chronic critical illness
have been reported in the UK [10], Canada [11], and the
USA [2]. High healthcare utilization results in increased
healthcare costs with one US study estimating the attrib-
utable costs as high as $35 billion or 1.4% of the US
healthcare expenditure [12]. Therefore, these patients
contribute small actual numbers but high cost and care
delivery burden to the ICU, hospital, and healthcare sys-
tem. Moreover, these patients experience worse clinical
outcomes with hospital mortality (20 to 49% [13]) and
1-year mortality (32 to 55% [14]) substantially higher
than patients that require a short ICU admission. Less
than half of these patients that survive ICU admission
will return home and therefore require post-acute
hospitalization institutional care [9].
Patients with P/CCI have unique and complex needs
that may be distinct from those of patients at the acute
stage of ICU admission and medical stabilization. There-
fore, these patients require a change in the clinical man-
agement plan and overall goals of care to a focus on
rehabilitation, symptom relief, discharge planning, and in
some cases, ventilation discontinuation or end-of-life care
[15]. Despite increasing recognition of the burden of P/
CCI for patients, families, and the healthcare system, and
differences in their care needs [16], few studies have been
conducted to inform development of ICU care quality
measures focused on actionable processes of care specific
to this patient population. Processes comprise things that
we do, or fail to do for our patients, i.e., treatment and
care [17]. Actionable processes of care are those that clini-
cians have direct control over [18], i.e., commencing the
weaning process or discontinuing sedation. Our group has
identified that processes of care such as weaning and
mobilization protocols infrequently include guidance
specific to patients with P/CCI [19]. Moreover, few ICUs
incorporate into practice those assessments and interven-
tions deemed pertinent including communication ad-
juncts, anxiety and dyspnea assessment, and access to
psychiatric services during ICU admission [19]. Quality
indicators are tools that indicate care quality and compare
actual care against ideal criteria [20]. Performance mea-
sures are tools to measure care quality. Existing indicators
of ICU care quality such as rates of central line infection,
ventilator-associated pneumonia, and unplanned extuba-
tion [21], and tools such as checklists that measure imple-
mentation of best practice [22], may not be sufficiently
inclusive in terms of actionable processes of care relevant
to patients with P/CCI.
At present, it is unclear if the absence of performance
measures for potentially actionable processes of care
specifically designed for patients with P/CCI contribute
to poor experience and adverse outcomes. Provision of
optimal care for these patients has implications for
health care spending on critical care services [10], health
care quality outcomes, and timely integration of appro-
priate services including chronic illness management,
rehabilitation, community services, and palliative care.
Additionally, the number of patients experiencing P/CCI
is predicted to grow exponentially over coming years
due to population aging and increased morbidity and
thus the need to optimize care for these patients is im-
perative [12]. Therefore, our objective is to identify the
processes of care, performance measures, quality indica-
tors, and outcomes including reports of patient/family
experience described in the current evidence base that
are relevant to P/CCI patients and their family members.
Methods
We prepared this review protocol using the Preferred
Reporting Items for Systematic Review and Meta-Analyses
Protocol (PRISMA-P) guidelines [23] and completed the
PRISMA-P checklist (Additional file 1). We registered the
protocol on International Prospective Register of Systematic
Reviews (PROSPERO) CRD42016052715.
Data sources and search strategy
We created a preliminary search strategy (Additional file 2)
as an iterative process with guidance from an experienced
information specialist. Search strategies will utilize a
combination of controlled vocabulary (e.g., “Intensive Care
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Units”, “Critical illness”) and keyword combinations (e.g.,
chronic or persistent) adjacent to (acute or critical or
intensive). Vocabulary and syntax will be adjusted across
databases. We will remove animal-only studies and opinion
pieces (e.g., editorials, letters). As we are including a range
of study designs, we will not apply study-specific filters.
Prior to search execution, a second information specialist
used the Peer Review for Electronic Search Strategies
(PRESS) template [24, 25] to review and approve the search
strategy. We will search the following electronic databases
(March 1980 to Nov 2016): Medline, CINAHL, Embase,
and the Web of Science. We will search systematic review
databases including the Cochrane Library, PROSPERO, and
the Joanna Briggs Institute. We will search major guideline
sites (e.g., CMA Infobase, National Guideline Clearing-
house) for clinical practice guidelines and policy docu-
ments, and websites of relevant professional societies for
practice recommendations relevant to our population of
interest. We will examine reference lists of relevant studies/
reviews for additional studies and will contact correspond-
ing authors for details of additional published/unpublished
work. We will search for unpublished and ongoing trials on
the http://apps.who.int/trialsearch website.
Study selection—inclusion and exclusion criteria
We will include all study designs except case series/reports
of less than 10 patients. We will exclude narrative and
systematic reviews but will screen those relevant to our
population of interest for discussion of additional processes
of care, quality indicators, or outcomes not present in
primary studies. We will exclude commentaries, editorials,
and opinion papers, and for pragmatic reasons, studies
reported in languages other than English.
Population
We will include studies describing their study population
(aged 18 years and older) using terms such as persistent
critical illness, chronic critical illness, and prolonged
mechanical ventilation or that describe a study popula-
tion admitted to a specialized weaning facility, long-term
acute care hospital, or respiratory high dependency unit.
Based on previous experience with this literature [26],
we are aware such terms are highly variable in the
duration of mechanical ventilation or ICU length of stay
used to define the study cohort. Therefore, we will in-
clude only studies that report on a cohort with an a
priori ICU length of stay of 7 days or more as an inclu-
sion criterion for the study (not as the mean or median
duration of stay of the enrolled cohort for that study).
We have selected this definition based on the consensus
definition used by Medicare and Medicaid in the USA
[27]. We will exclude studies describing a long-term
mechanical ventilation population, defined as patients
with no expectation of weaning, from care venues other
than those described above, and studies describing pa-
tient cohorts receiving mechanical ventilation at home.
Intervention
We will include studies reporting on actionable (i.e., those
that clinicians have direct control over) processes of care
(e.g., weaning, mobilization, or sleep protocols; symptom
assessment; family involvement) or interventions (e.g.,
communication devices) specific to our patient population
of interest. We will include studies reporting the experi-
ences of patients with P/CCI and their family members,
clinician perspectives, as well as studies describing unit
organizational structure (e.g., staffing, daily routines) rele-
vant to these patients. We will exclude studies examining
predictors of P/CCI and those describing only cohort char-
acteristics and outcomes (e.g., length of stay, mortality)
without description of processes of care, intervention, or
patient or family experience.
Comparator
We will include studies that compare processes of
care or interventions to usual care, another process of
care or intervention, as well as studies without a
comparator group.
Outcomes
Our primary outcome is to determine actionable pro-
cesses of care and interventions deemed relevant to P/
CCI patients and their family members. Secondary
outcomes include (1) quality indicators (tools that
indicate care quality) and performance measures
(measures of quality) considered relevant to our popu-
lation of interest and (2) themes related to patient and
family experience.
Study selection and data extraction
Using a pre-designed screening tool listing inclusion and
exclusion criteria, two authors (LR/LI) will independ-
ently examine study titles and abstracts. Screening will
be managed using Endnote 17; all decisions will be re-
corded in an Excel file. We will obtain full text articles
considered potentially relevant by either author and
examine for eligibility. Disagreements will be resolved
through discussion and referred to a third author for
arbitration if necessary. Two authors in pairs will inde-
pendently extract study data using a standardized form;
all data extraction will be checked for accuracy by a
third author. We will extract data on the country(ies)
study was performed in, care venue type and characteris-
tics, patient age range, diagnostic categories, severity of ill-
ness, inclusion and exclusion criteria, verbatim description
of care processes, interventions, and performance measures
as well as themes related to patient and family experience.
We will also extract study outcomes, i.e., what was
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measured, how it was measured, and study results. Data
extractors will not be blinded to study citations.
Risk of bias reporting
Two investigators will independently assess risk of bias
using the Cochrane Risk of Bias tool for randomized and
quasi-randomized studies and the Scottish Intercollegi-
ate Guidelines Network (SIGN) checklists for cohort
and case–control studies for non-randomized studies
[28]. For qualitative studies, we will assess study quality
using the multi-dimensional concept of quality recom-
mended by the Cochrane Quality and Intervention
Methods Group [29] that includes (1) quality of report-
ing, e.g., explicitness in reporting all study aspects; (2)
methodological rigor, e.g., validity and reliability of study
design and process; and (3) overall conceptual depth and
breadth, e.g., if stated study aims, rationale, or theory (if
the study is explicitly theoretically informed) are
reflected in the study design, process, and findings. We
will also determine if the methods and conceptual
underpinning are congruent. Two authors will inde-
pendently appraise study quality using the 10 questions
of the 2014 Critical Appraisal Skills Programme (CASP)
quality assessment tool for qualitative studies [30]. Each
of these 10 questions will be answered as “yes”, “no”, or
“unclear”. The CASP tool does not consider the more
conceptual or theoretical aspects of qualitative studies,
the same two authors will independently appraise study
quality using the seven criteria outlined by Popay [31].
These seven criteria include (1) Illumination of subjective
meaning; (2) Adaptation and responsiveness of research
design; (3) Sample provides appropriate knowledge; (4)
Description sufficiently detailed; (5) Sources of knowledge
compared and contrasted; (6) Shift from description to ana-
lysis and interpretation; and (7) Claims for generalizability.
We will present quality assessments in tabular format.
Approach to evidence synthesis, analysis, and
interpretation
We will summarize our search results in a PRISMA
study flow diagram [32]. We will generate summary
tables reporting counts and proportions (categorical
variables) and means and standard deviations or median
and interquartile ranges (continuous variables) as reported
by study authors of study and cohort characteristics as
well as study results. We will catalogue descriptions of
care processes, interventions, quality metrics, and tools
described in eligible studies. Due to the anticipated diver-
sity in study designs as well as diversity in processes of
care, interventions, quality indicators, and measures under
evaluation of included studies, we will not perform meta-
analyses but will generate a narrative synthesis of study re-
sults. We anticipate qualitative data will describe patient
and family experience or clinician perspectives. We will
generate tables of author reported categories, themes, and
subthemes. We will undertake content analysis [33, 34] to
quantify common categories and themes within these cat-
egories. We will categorize quality of care components
from quantitative and qualitative studies using the
conceptual framework of structure, process, and outcomes
[35]. We will generate descriptive statistics using SPSS
Version 24 (Armonk, NY).
Dealing with missing data
We (LR) will attempt to contact study authors for unre-
ported data or clarification of study methods using a max-
imum of three e-mails. If data remains unavailable, we will
analyze the available data and report the potential impact
of missing data in the discussion section.
Subgroup and sensitivity analyses
We do not plan to undertake subgroup or sensitivity
analyses.
Publication bias
We do not intend to examine publication bias.
Discussion
The existence of a distinct cohort of relatively low
volume, high cost, and poor outcome patients requir-
ing mechanical ventilation and ICU admission for
longer than the average patient has long been recog-
nized [2, 9, 10, 36–38]. However, for the most part,
studies of the effectiveness of interventions in the ICU
focus on the acute phase of critical illness. Similarly, qual-
ity indicators, measures, and tools to evaluate quality of
care, and patient or family member experience, have not
been developed with patients with P/CCI in mind, nor
have they been developed with the patient and family per-
spective at the forefront. At present, the absence of quality
and performance measures for potentially actionable pro-
cesses of care specifically designed for patients with P/CCI
may contribute to poor experience and adverse outcomes.
This review is the first step in an item generation
process to identify processes of care, quality indicators,
performance measures, and outcomes that are important
from the perspective of patients experiencing P/CCI,
their family members, and the clinicians that treat them.
Subsequent phases of this work include further item
generation via ICU survivor, family member, and clin-
ician interviews. This phase will be followed by item re-
duction via rigorous consensus based methods including
a two-round Delphi process and an adaptation of the
nominal group technique used for priority setting part-
nerships by the James Lind Alliance. The James Lind
Alliance is a non-profit organization that pioneered
setting priorities for “treatment uncertainties” of direct
relevance and benefit to patients and clinicians using the
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principles of equal contribution and transparency [39].
Our overall aim is to inform the development of tools to
improve care quality and experience of patients experi-
encing P/CCI and their family members.
Conclusion
In summary, patients with P/CCI are a small but high cost
and care delivery burden that experience poor clinical out-
comes. Due to their unique and complex needs, existing
indicators and measures of ICU care quality and perform-
ance may not be sufficiently relevant to these patients.
Our systematic review comprises the first phase of the
development of quality metrics and tools designed to
measure processes of care, outcomes, and experience rele-
vant of this patient population, their family members, and
the clinicians that treat them.
Registration
This systematic review is registered with PROSPERO, an
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